Evidence map›Paper›PMID 35011521›Full record

ArticleMolecules (Basel, Switzerland)2022

Biochemical and Structural Analysis of a Glucose-Tolerant β-Glucosidase from the Hemicellulose-Degrading

In Jung Kim, Uwe T Bornscheuer, Ki Hyun Nam

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Optimisation ofInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

In Jung KimDepartment of Biotechnology and Enzyme Catalysis, Institute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany.
Uwe T BornscheuerDepartment of Biotechnology and Enzyme Catalysis, Institute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany.ORCID 0000-0003-0685-2696
Ki Hyun NamDepartment of Biotechnology and Enzyme Catalysis, Institute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany.ORCID 0000-0003-3268-354X
Universität Greifswald · DEPohang University of Science and Technology · KR

Funding

National Research Foundation of Korea 2017M3A9F6029736National Research Foundation of Korea 2017R1D1A1B03033087National Research Foundation of Korea 2020R1A6A3A03039153National Research Foundation of Korea 2021R1I1A1A01050838
6 · The paper itself

Abstract

β-Glucosidases (Bgls) convert cellobiose and other soluble cello-oligomers into glucose and play important roles in fundamental biological processes, providing energy sources in living organisms. Bgls are essential terminal enzymes of cellulose degradation systems and attractive targets for lignocellulose-based biotechnological applications. Characterization of novel Bgls is important for broadening our knowledge of this enzyme class and can provide insights into its further applications. In this study, we report the biochemical and structural analysis of a Bgl from the hemicellulose-degrading thermophilic anaerobe

Indexed as

Amino Acid Sequencebeta-GlucosidaseBiodegradation, EnvironmentalChemical PhenomenaGlucoseModels, MolecularMolecular StructurePolysaccharidesProtein ConformationStructure-Activity RelationshipThermoanaerobacteriumbeta-GlucosidaseGlucosehemicellulosePolysaccharidesBglcellulose degradationglucose toleranceglycoside hydrolaseThermoanaerobacterium saccharolyticumTris inhibitionβ-glucosidase

Identifiers

PMID35011521
PMCPMC8746653
OpenAlexW4206738128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.